Nanotherapy for posterior eye diseases
IP Kaur, S Kakkar - Journal of Controlled Release, 2014 - Elsevier
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
the posterior segment. Furthermore, most of these diseases lead to partial or complete …
Therapies based on nanoparticles for eye drug delivery
A Meza-Rios, J Navarro-Partida… - Ophthalmology and …, 2020 - Springer
Eye drug delivery, particularly to the retina, is a technical hurdle that needs to be solved and
represents an ongoing current important medical field. Posterior segment eye diseases are …
represents an ongoing current important medical field. Posterior segment eye diseases are …
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: Challenges analysis and recent advances
R Wang, Y Gao, A Liu, G Zhai - Journal of drug targeting, 2021 - Taylor & Francis
Posterior segment eye disease is a leading cause of irreversible vision impairment and
blindness. As the unique organ for vision, eyes are protected by various protective barriers …
blindness. As the unique organ for vision, eyes are protected by various protective barriers …
Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye
Y Wang, X Xu, Y Gu, Y Cheng, F Cao - Expert opinion on drug …, 2018 - Taylor & Francis
Introduction: Considering that the number of patients afflicted by posterior eye diseases is
increasing, effective drug delivery is currently in high clinical demand. Topical administration …
increasing, effective drug delivery is currently in high clinical demand. Topical administration …
Recent perspectives in ocular drug delivery
R Gaudana, J Jwala, SHS Boddu, AK Mitra - Pharmaceutical research, 2009 - Springer
Anatomy and physiology of the eye makes it a highly protected organ. Designing an effective
therapy for ocular diseases, especially for the posterior segment, has been considered as a …
therapy for ocular diseases, especially for the posterior segment, has been considered as a …
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases
C Wang, Y Pang - Advanced drug delivery reviews, 2023 - Elsevier
Eye drops are the most accessible therapy for ocular diseases, while inevitably suffering
from their lower bioavailability which highly restricts the treatment efficacy. The introduction …
from their lower bioavailability which highly restricts the treatment efficacy. The introduction …
Ocular drug delivery: present innovations and future challenges
Ocular drug delivery has always been a challenge for ophthalmologists and drug-delivery
scientists due to the presence of various anatomic and physiologic barriers. Inimitable static …
scientists due to the presence of various anatomic and physiologic barriers. Inimitable static …
[HTML][HTML] Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases
Diseases affecting the anterior segment of the eye are the primary causes of vision
impairment and blindness globally. Drug administration through the topical ocular route is …
impairment and blindness globally. Drug administration through the topical ocular route is …
Nano-based drug delivery system: recent strategies for the treatment of ocular disease and future perspective
The structure of the eye is very complex in nature which makes it a challenging task for
pharmaceutical researchers to deliver the drug at the desired sites via different routes of …
pharmaceutical researchers to deliver the drug at the desired sites via different routes of …
Trends in formulation approaches for sustained drug delivery to the posterior segment of the eye
The eye, an intricate organ comprising physical and physiological barriers, poses a
significant challenge for ophthalmic physicians seeking to treat serious ocular diseases …
significant challenge for ophthalmic physicians seeking to treat serious ocular diseases …